Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis

被引:9
|
作者
Koido, Kati [1 ,2 ]
Innos, Juergen [1 ,2 ]
Haring, Liina [2 ,3 ]
Zilmer, Minkel [2 ,4 ]
Ottas, Aigar [2 ,4 ]
Vasar, Eero [1 ,2 ]
机构
[1] Univ Tartu, Dept Physiol, Inst Biomed & Translat Med, Tartu, Estonia
[2] Univ Tartu, Ctr Excellence Genom & Translat Med, Tartu, Estonia
[3] Tartu Univ Hosp, Psychiat Clin, Tartu, Estonia
[4] Univ Tartu, Inst Biomed & Translat Med, Dept Biochem, Tartu, Estonia
来源
FRONTIERS IN NEUROSCIENCE | 2016年 / 10卷
关键词
taurine; spermine; cytokines; growth factors; epidermal growth factor; NMDA receptors; first-episode psychosis; antipsychotic treatment; D-ASPARTATE RECEPTOR; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; MODULATION; EXPRESSION; INJURY; PLASMA;
D O I
10.3389/fnins.2016.00331
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study evaluated the levels of two amino acid derivatives taurine and spermine in first episode psychosis (FEP) patients and their response to antipsychotic treatment. The levels of taurine and spermine were significantly up-regulated in antipsychotic-naive FEP patients compared to control subjects (CS). Treatment of FEP patients with antipsychotic drugs significantly reduced the positive symptoms of schizophrenia. This positive effect was accompanied by a significant reduction of taurine and spermine to the levels measured in CS. General linear model was used to establish associations of taurine and spermine with the levels of cytokines and growth factors, measured in our previous experiments using the same study sample. There was a strong association between taurine and epidermal growth factor (EGF). Both biomarkers significantly correlated with the disease symptoms as well as with the effectiveness of antipsychotic treatment. Accordingly one can conclude that taurine and EGF belong to the signature of FEP. Most probably they reflect altered oxidative stress and corrupted function of N-methyl-D-aspartate (NMDA) receptors in FEP.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Stigma and access to care in first-episode psychosis
    Kular, Ariana
    Perry, Benjamin I.
    Brown, Luke
    Gajwani, Ruchika
    Jasini, Rubina
    Islam, Zoebia
    Birchwood, Max
    Singh, Swaran P.
    EARLY INTERVENTION IN PSYCHIATRY, 2019, 13 (05) : 1208 - 1213
  • [32] Experience of recovery from a first-episode psychosis
    Eisenstadt, Paula
    Monteiro, Vera B.
    Diniz, Matheus J. A.
    Chaves, Ana C.
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 (04) : 476 - 480
  • [33] Hopelessness and first-episode psychosis: A longitudinal study
    Aguilar, EJ
    Haas, G
    Manzanera, FJ
    Hernandez, J
    Gracia, R
    Rodado, MJ
    Keshavan, MS
    ACTA PSYCHIATRICA SCANDINAVICA, 1997, 96 (01) : 25 - 30
  • [34] Optimal haloperidol dosage in first-episode psychosis
    Zhang-Wong, J
    Zipursky, RB
    Beiser, M
    Bean, G
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1999, 44 (02): : 164 - 167
  • [35] Measuring quality of life in first-episode psychosis
    Melle, I
    Friis, S
    Haahr, U
    Johannesen, JO
    Larsen, TK
    Opjordsmoen, S
    Roessberg, JI
    Rund, BR
    Simonsen, E
    Vaglum, P
    McGlashan, T
    EUROPEAN PSYCHIATRY, 2005, 20 (07) : 474 - 483
  • [36] Improving outcomes of first-episode psychosis: an overview
    Fusar-Poli, Paolo
    McGorry, Patrick D.
    Kane, John M.
    WORLD PSYCHIATRY, 2017, 16 (03) : 251 - 265
  • [37] Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
    Leppik, Liisa
    Kriisa, Kart
    Koido, Kati
    Koch, Kadri
    Kajalaid, Karolin
    Haring, Liina
    Vasar, Eero
    Zilmer, Mihkel
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [38] Synaptic Elimination in First-Episode Psychosis Subjects
    Engberg, Goran
    Xu, Chengai
    Sellgren, Carl
    Fatouros-Bergman, Helena
    Blennow, Kaj
    Zetterberg, Henrik
    Brinkmalm, Anna
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 169 - 170
  • [39] Premorbid negative symptoms in first-episode psychosis
    Cuesta, Manuel J.
    Peralta, Victor
    Gil, Patxi
    Artamendi, Maria
    EUROPEAN JOURNAL OF PSYCHIATRY, 2007, 21 (03) : 220 - 229
  • [40] Pharmacotherapy challenges in patients with first-episode psychosis
    Abdel-Baki, Amal
    Ouellet-Plamondon, Clairelaine
    Malla, Ashok
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 138 : S3 - S14